Concepedia

Emily Branchard

EB

Statistics

Publications

6

Citations

204

H-Index

6

Active since

2017

Affiliations

University of Toronto(Current)

Princess Margaret Cancer Centre

University Health Network

St. Michael's Hospital

Sunnybrook Research Institute

Emily Branchard is an author at University of Toronto specializing in pharmacology, medicine, and oncology.

Publications per year

2017–2022

6

Publications

6

A pilot window-of-opportunity study of preoperative fluvastatin in localized prostate cancer

Joseph Longo, Robert J. Hamilton, Mehdi Masoomian et al. · Prostate Cancer and Prostatic Diseases · 2020 · 56 citations · Full text

, , +11

Cell confluence regulates claudin-2 expression: possible role for ZO-1 and Rac

Yasaman Amoozadeh, Shaista Anwer, Qinghong Dan et al. · American Journal of Physiology-Cell Physiology · 2017 · 42 citations · Full text

, , +17

Mevalonate Pathway Inhibition Slows Breast Cancer Metastasis via Reduced <i>N</i>-glycosylation Abundance and Branching

Rosemary Yu, Joseph Longo, Jenna E. van Leeuwen et al. · Cancer Research · 2021 · 40 citations · Full text

, , +17

The mevalonate pathway is an actionable vulnerability of t(4;14)-positive multiple myeloma

Joseph Longo, Petr Smirnov, Zhihua Li et al. · Leukemia · 2020 · 35 citations · Full text

, , +16

Computational pharmacogenomic screen identifies drugs that potentiate the anti-breast cancer activity of statins

Jenna E. van Leeuwen, Wail Ba-Alawi, Emily Branchard et al. · Nature Communications · 2022 · 19 citations · Full text

, , +13

1–5 of 6